[
    {
        "id": "osp-1476",
        "type": "article-journal",
        "title": "Diagnostic Usefulness of Tru-Cut Biopsy in the Diagnosis of Breast Lesions",
        "author": [
            {
                "family": "Rikabi",
                "given": "Ammar"
            },
            {
                "family": "Hussain",
                "given": "Sufia"
            }
        ],
        "URL": "https://omanscience.com/en/articles/diagnostic-usefulness-of-tru-cut-biopsy-in-the-diagnosis-of-breast-lesions",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2013
                ]
            ]
        },
        "container-title": "Oman Medical Journal",
        "DOI": "10.5001/omj.2013.32",
        "publisher": "Oman Medical Specialty Board",
        "ISSN": "1999-768X",
        "abstract": "Objective: To evaluate the usefulness of Tru-Cut biopsy (TCB) in the diagnosis of breast lesions. Methods: An observational non-interventional cross-sectional review was performed of all TCB reports of a mass or lesion observed in patients admitted between January 2008 and December 2010, at King Khalid University Hospital, Riyadh, Saudi Arabia. Results: A total of 275 trucut biopsies were performed during the study period. Histopathology showed 92 (33.5%) malignant lesions, 177 (64.3%) benign lesions and 6 (2.2%) suboptimal or suspicious lesions. Repeat trucut biopsies were done in 29 (16.4%) of the benign cases, 12 (13%) of the malignant cases, and for 6 inconclusive specimens which showed 4 of the 29 benign cases to be malignant lesions, and 5 of the 6 inconclusive cases were also malignant lesions. All 12 malignant cases that had repeat trucut biopsy had a confirmed diagnosis of malignancy. Trucut biospy had a sensitivity of 95.1%, specificity of 100%, positive predictive value of 100%, negative predictive value of 97.2%, and an overall diagnostic accuracy of 98.2%. Conclusion: Trucut biopsy is an accurate alternative to fine needle aspiration cytology in the diagnosis of breast lesions with a high diagnostic accuracy of 98.2%."
    }
]